Ono Pharma Partners With Aitia on Causal AI Drug Discovery
OSAKA, Japan and CAMBRIDGE, Mass., September 2, 2026 Ono Pharmaceutical Co., Ltd. has entered into a drug discovery partnership...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
OSAKA, Japan and CAMBRIDGE, Mass., September 2, 2026 Ono Pharmaceutical Co., Ltd. has entered into a drug discovery partnership...
